Carlos Ferrándiz

6.4k citations
175 papers · 3.5k indexed · h-index 32

Carlos Ferrándiz

168 papers receiving 3.4k citations

Peers

Carlos Ferrándiz
Comparison fields: 5 of 117
  • Dermatology 1.9k
  • Immunology 1.2k
  • Immunology and Allergy 297
  • Epidemiology 1.2k
  • Oncology 900
Replace Emmilia Hodak with:
Emmilia Hodak Israel
Eduardo Fonseca Spain
Elizabeth Lazaridou Greece
R.A.C. GRAHAM-BROWN United Kingdom
Jerome L. Shupack United States
Shinichi Imafuku Japan
Bárður Sigurgeirsson Iceland
Martine Bagot France
Henry H. Roenigk United States
Michael Sticherling Germany
Carlos Ferrándiz relative to Emmilia Hodak Israel Emmilia Hodak's profile →
Citations per field
00.5×1.5×2.1×
Emmilia Hodak · 1×
Citations per year

Countries citing papers authored by Carlos Ferrándiz

Since Specialization
Citations

This map shows the geographic impact of Carlos Ferrándiz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos Ferrándiz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos Ferrándiz more than expected).

Fields of papers citing papers by Carlos Ferrándiz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos Ferrándiz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos Ferrándiz. The network helps show where Carlos Ferrándiz may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Carlos Ferrándiz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Carlos Ferrándiz Line = papers co-authored together Carlos Ferrándiz links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20240
2 20205
3 2019114
4 201715
5 201516
6 201232
7 201128
8 201116
9 201125
10 201051
11 200816
12 20088
13 20060
14 200511
15 200372
16 200234
17
Lipoatrofia semicircular de los muslos
20006
18 19993
19 199616
20 199562

About Carlos Ferrándiz

Carlos Ferrándiz is a scholar working on Dermatology, Immunology and Epidemiology, having authored 175 papers that have together received 3.5k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (41 papers), Dermatology and Skin Diseases (28 papers), Nonmelanoma Skin Cancer Studies (28 papers), Autoimmune Bullous Skin Diseases (24 papers), Cutaneous Melanoma Detection and Management (20 papers), Cutaneous lymphoproliferative disorders research (19 papers), Cancer and Skin Lesions (18 papers) and Nail Diseases and Treatments (17 papers). The work is most often cited by research in Dermatology (1.9k citations), Immunology (1.2k citations) and Immunology and Allergy (297 citations). Carlos Ferrándiz has collaborated with scholars based in Spain, United States and Germany. Frequent co-authors include María Teresa Fernández‐Figueras, L. Puig, J.M. Carrascosa, Isabel Bielsa, J.M. Carrascosa, Miquel Ribera, Mireia del Toro, Adolfo J. Ariza, Eva Musulén and Aram Boada. Their work appears in journals such as PLoS ONE, The American Journal of Medicine and The American Journal of Human Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026